Your browser doesn't support javascript.
loading
Number of Disected Lymph Nodes In Colorectal Cancer Patients SubmittedTo Radical Surgery: The Quality of Oncology Treatment
Bepu Junior, Paulo; Ferreira, Fábio de Oliveira; Santos, Erika Maria Monteiro; Aguiar Junior, Samuel; Nakagawa, Wilson Toshihiko; Lopes, Ademar; Rossi, Benedito Mauro.
  • Bepu Junior, Paulo; Hospital do Câncer A.C. Camargo. São Paulo. BR
  • Ferreira, Fábio de Oliveira; Hospital do Câncer A.C. Camargo. Departamento de Pélvica. São Paulo. BR
  • Santos, Erika Maria Monteiro; Hospital do Câncer A.C. Camargo. Departamento de Pélvica. São Paulo. BR
  • Aguiar Junior, Samuel; Hospital do Câncer A.C. Camargo. Departamento de Pélvica. São Paulo. BR
  • Nakagawa, Wilson Toshihiko; Hospital do Câncer A.C. Camargo. Departamento de Pélvica. São Paulo. BR
  • Lopes, Ademar; Hospital do Câncer A.C. Camargo. Departamento de Pélvica. São Paulo. BR
  • Rossi, Benedito Mauro; Hospital do Câncer A.C. Camargo. Departamento de Pélvica. São Paulo. BR
Appl. cancer res ; 26(1): 27-33, Jan.-Mar. 2006.
Artigo em Inglês | LILACS, Inca | ID: lil-442323
ABSTRACT
Introduction: the correct evaluation of lymph node disease influences the therapeutical decisions of colon and rectal cancer(CRC) patients. The number of dissected lymph nodes is a variable that have prognostic value and serves as an indicator of thequality of oncology treatment. For a correct evaluation of N stage to be accepted, the minimum number of dissected lymphnodes considered must be 12. In rectal cancer patients submitted to neoadjuvant radiochemotherapy, the interpretation of thenumber of dissected lymph nodes remains inconclusive. Objective: is to evaluate the number of dissected lymph nodes in CRCpatients submitted to curative surgery and determine this latter impact in oncologic treatment results. In cases of rectalcancer, to study the effect of neoadjuvant radiochemotherapy in dissected lymph nodes count. Method: in the period 1991-2004, 852 CRC patients were treated in Hospital A. C. Camargo . Patients with metastases at the time of diagnosis,synchronous and metachronic tumors, total colectomy or total proctocolectomy and hereditary colorectal cancer were excluded.The sample was constituted by 423 patients with sporadic colorectal adenocarcinoma who undergone curative radical surgery(168 colon primary tumors and 255 rectal tumors). Colon cancer patients, treated primarily by surgery, had also receivedadjuvant chemotherapy (5-FU) according to risk criteria. Rectal cancer patients with fixed or half-fixed injuries or clinicallycompromised lymph nodes (T3, T4 or N+) had received neoadjuvant radiochemotherapy, followed by surgery and chemotherapy(5-FU). Results: the median of the number of dissected lymph nodes in colon cancer patients was 17. In the case of rectalcancer patients, the median of dissected lymph nodes in the groups with and without neoadjuvant radiochemotherapy had beenrespectively 9 and 15 (p<0.001). 5-year specific survival rates for colon and rectal cancer patients were respectively...
Assuntos
Texto completo: DisponíveL Índice: LILACS (Américas) Assunto principal: Neoplasias Retais / Neoplasias Colorretais Tipo de estudo: Estudo prognóstico Limite: Feminino / Humanos / Masculino Idioma: Inglês Revista: Appl. cancer res Assunto da revista: Neoplasias Ano de publicação: 2006 Tipo de documento: Artigo País de afiliação: Brasil Instituição/País de afiliação: Hospital do Câncer A.C. Camargo/BR

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: LILACS (Américas) Assunto principal: Neoplasias Retais / Neoplasias Colorretais Tipo de estudo: Estudo prognóstico Limite: Feminino / Humanos / Masculino Idioma: Inglês Revista: Appl. cancer res Assunto da revista: Neoplasias Ano de publicação: 2006 Tipo de documento: Artigo País de afiliação: Brasil Instituição/País de afiliação: Hospital do Câncer A.C. Camargo/BR